XBiotech XBIT
NASDAQ XBIT
$2.19 +0.01 (+0.46%)
At close: Sep 30, 2026 · 4:00 PM EDT

XBiotech (XBIT) Long-Term Deferred Tax (2019 - 2022)

Updated

XBiotech (XBIT) posted Long-Term Deferred Tax of $772,000 for Q3 2022, up 20.2% from $642,000 a year earlier and up 82.9% from the prior quarter.

Analysis

XBiotech (XBIT) Long-Term Deferred Tax (2019 - 2022) Analysis & Trends

At the end of FY2020, XBiotech's Long-Term Deferred Tax came in at $533,000, up 20.3% from FY2019.

  • In prior years, XBiotech's Long-Term Deferred Tax was $443,000 in FY2019.
  • The Q3 2022 figure stands as the highest quarterly Long-Term Deferred Tax in data going back to Q4 2019.
  • On a year-over-year basis, Long-Term Deferred Tax increased in five of the last six quarters, with growth averaging 19.4%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 XBiotech 66.77 Mn 66.77 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2022 772,000.00
Jun 30, 2022 422,000.00
Sep 30, 2021 642,000.00
Jun 30, 2021 642,000.00
Mar 31, 2021 533,000.00
Dec 31, 2020 533,000.00
Sep 30, 2020 443,000.00
Jun 30, 2020 443,000.00
Mar 31, 2020 443,000.00
Dec 31, 2019 443,000.00
API Access

XBiotech Long-Term Deferred Tax API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-deferred-tax&ticker=XBIT&period=max&api_key=YOUR_API_KEY